Type 1 interferon (T1IFN) signaling promotes inflammation and lupus pathology, but its role in autoreactive B cell development in the antibody-forming cell (AFC) and germinal center (GC) pathways is unclear. Using a lupus model that allows for focused study of the AFC and GC responses, we show that T1IFN signaling is crucial for autoreactive B cell development in the AFC and GC pathways. Through bone marrow chimeras, DNA-reactive B cell transfer, and GCspecific Cre mice, we confirm that IFNαR signaling in B cells promotes autoreactive B cell development into both pathways. Transcriptomic analysis reveals gene expression alterations in multiple signaling pathways in non-GC and GC B cells in the absence of IFNαR. Finally, we find that T1IFN signaling promotes autoreactive B cell development in the AFC and GC pathways by regulating BCR signaling. These data suggest value for anti-IFNαR therapy in individuals with elevated T1IFN activity before clinical disease onset. 
INTRODUCTION
Systemic lupus erythematosus (SLE) is a multifactorial autoimmune disease characterized by the production of DNA-and RNA-based autoantibodies (autoAbs). Loss of self-tolerance initiates SLE, but further amplification of autoimmune responses is required for the progression to end-stage organ pathology, which includes kidney glomerulonephritis (Nguyen et al., 2002) . The autoimmune responses and pathology in SLE-prone mice and SLE patients are accelerated by pro-inflammatory cytokines, including interferons (Agrawal et al., 2009; Bennett et al., 2003; Crow, 2014; Liu and Davidson, 2013; Lourenço and La Cava, 2009; Mathian et al., 2005; Nickerson et al., 2013; Santiago-Raber et al., 2003) . Several type 1 interferon (T1IFN)-targeted therapies (sifalimumab, rontalizumab, and anifrolumab) have been proposed for SLE but without an understanding of mechanisms by which T1IFN signaling may promote SLE development. The contribution of T1IFN signaling in the initial loss of tolerance is not clear. In SLE patients, an elevated T1IFN activity is detected before disease onset and continues to rise with disease progression (Bennett et al., 2003; Munroe et al., 2016) ; thus, T1IFN is likely involved both in initial loss of tolerance and subsequent disease progression.
Multiple tolerance checkpoints during B cell development in the bone marrow and in the periphery maintain B cell tolerance. The extra-follicular antibody-forming cell (AFC) and follicular germinal center (GC) pathways are two major peripheral B cell tolerance checkpoints (Cappione et al., 2005; Vinuesa et al., 2009; William et al., 2002) . Unlike microbial antigen-induced AFC and GC responses that generate anti-microbial antibodies (Abs), in autoimmunity, AFCs and GCs spontaneously develop in the absence of detectable microbial infections or purposeful immunization (called spontaneous AFCs, Spt-AFCs, and spontaneous GCs [Spt-GCs] ) and produce autoantibodies (autoAbs) (Cappione et al., 2005; Domeier et al., 2017; Luzina et al., 2001; Tiller et al., 2010; Vinuesa et al., 2009; Woods et al., 2015) . Autoimmune-prone mice and humans exhibit elevated Spt-AFC and Spt-GC responses (Domeier et al., 2017; Luzina et al., 2001; Tiller et al., 2010; Wong et al., 2015; Woods et al., 2015; Rahman et al., 2007; Fukuyama et al., 2005) that correlate well with the increased autoAb production and numbers of autoAb-producing AFCs.
Spt-AFCs and Spt-GCs are known to play a role in autoimmunity (Domeier et al., 2017; Luzina et al., 2001; Rahman et al., 2007; Fukuyama et al., 2005) , but the mechanisms that drive autoreactive B cell development in the AFC and GC pathways are poorly understood. Although previous studies revealed elevated short-lived AFC and GC B cell responses in pre-autoimmune lupus-prone mice upon IFNα treatment (Mathian et al., 2011 , the mechanisms by which T1IFN signaling alters B cell tolerance and promotes autoreactive B cell development through the AFC and GC pathways are not defined. To study the role of T1IFN signaling in loss of B cell tolerance and autoreactive B cell development in the AFC and GC pathways, we used the B6.Sle1b model, which harbors the SLAM locus from the lupus-prone NZM2410 strain (Kumar et al., 2006; Wandstrat et al., 2004; Wong et al., 2012 Wong et al., ,2015 . Mutations in the SLAM family genes within the Sle1b sublocus promote elevated Spt-AFC, Spt-GC, and autoAb responses (Wong et al., 2012 (Wong et al., , 2015 . However, B6.Sle1b mice do not develop a phenotype of chronic SLE without other immune-activating loci (i.e., Sle2, Sle3, yaa, and lpr), making this model particularly well suited for studying loss of B cell tolerance and autoreactive B cell development in the AFC and GC pathways without the confounding effects of systemic inflammation (Morel et al., 2000; Nguyen et al., 2002) .
Here, we report that T1IFN signaling via IFNαR plays an important role in elevated Spt-AFC, Spt-GC, and autoAb responses in B6.Sle1b mice. Using B-cell-specific bone marrow chimeras and a transgenic DNA-reactive HKIR B cell transfer system, we confirm that Bcell-intrinsic IFNαR signaling is required for altered B cell selection and autoreactive B cell development in the AFC and GC pathways. Transcriptional data indicate that T1IFN signaling in non-GC and GC B cells promotes autoreactive B cell development at the AFC and GC stages and does so by regulating genes in several crucial signaling pathways, such as cytokine signaling, B cell receptor (BCR) signaling, and transcriptional regulation (including nuclear factor κB [NF-κB] signaling). Our data further confirm that IFNαR signaling regulates BCR signaling at the naive and GC B cell stages. Additionally, using a Cre-loxbased approach, we showed that IFNαR signaling in B cells at the GC stage is required for elevated Spt-GC responses and the production of IgG2c autoAbs in B6.Sle1b mice. Collectively, these results indicate that IFNαR signaling in B cells maintains BCR signaling beyond the threshold required for effective tolerance, causing loss of B cell tolerance and driving autoreactive B cell development into the AFC and GC pathways in autoimmuneprone B6.Sle1b mice.
RESULTS

Type 1 Interferon Signaling Is Essential for Elevated Spt-AFC and Spt-GC Responses in B6.Sle1b Mice
Given the increase in T1IFN expression prior to the onset of SLE (Munroe et al., 2016) , we asked whether T1IFN signaling contributed to increased autoAb-producing Spt-AFC and Spt-GC responses in B6.Sle1b mice (Wong et al., 2012 (Wong et al., , 2015 . We first measured surface expression of IFNαR on B and T cells. Whereas IFNαR expression was higher on B220 + Fas hi GL-7 hi GC B cells than B220 + Fas low GL-7 low non-GC B cells, we found reduced expression of IFNαR on CD4 + PD-1 hi CXCR5 hi follicular helper T (Tfh) cells compared to CD4 + PD-1 low CXCR5 low naive T cells and GC B cells in 3-month-old female B6 and B6.Sle1b mice ( Figure 1A ). Using 3-and 6-month-old B6. Figure 1D ). Additionally, Sle1b.IFNαR 1 −/− mice exhibited a reduced number of splenic immunoglobulin G (IgG)+ AFCs than B6.Sle1b control mice, but the number of IgM + AFCs was not significantly different among the strains ( Figures 1E and 1F ). We also observed decreased total serum IgG titers in Sle1b.IFNαR 1 −/− mice ( Figure 1H ), including a reduction in IgG 2c ( Figure 1J ) compared to B6.Sle1b mice. No significant differences in IgM ( Figure 1G ) and IgG 1 ( Figure 1I ) serum titers were observed between B6.Sle1b and Sle1b.IFNαR 1 −/− mice. These reduced responses in B6.Sle1b mice in the absence of IFNαR signaling were not due to a major defect in primary B cell development in the bone marrow and in the periphery ( Figure S1 ). These data indicate that IFNαR signaling in autoimmune-prone B6.Sle1b mice is required for the development of elevated Spt-GC response, increased numbers of IgG + Spt-AFCs, and increased production of IgG and IgG 2c antibodies in vivo.
We next asked whether decreased Spt-GC and Spt-AFC responses in Sle1b.IFNαR 1 −/− mice caused a reduction in anti-nuclear antibody (ANA) reactivity. We observed a significant decrease in the number of double-stranded DNA (dsDNA), histone, and nucleosome-specific AFCs (Figures 2A-2D ) in the spleens and reduced serum autoAbs to these self-antigens in Sle1b.IFNαR 1 −/− mice compared to B6.Sle1b mice ( Figures 2E-2G ). Together, these data show that IFNαR signaling is required for the regulation of Spt-GC and Spt-AFC responses, leading to autoAb production in lupus-prone B6.Sle1b mice.
Previous studies in the BXD2 model of SLE demonstrated that T1IFN increases follicular entry of marginal zone B cells (MZBs) carrying apoptotic cell-derived self-antigens and causes loss of marginal zone macrophages (MZMs) (Li et al., 2015; Wang et al., 2010) . Subsequently, T1IFN was shown to promote elevated Spt-GC responses in BXD2 mice (Li et al., 2015; Wang et al., 2010) . Thus, we asked whether MZM and MZB populations were altered in B6.Sle1b and Sle1b.IFNαR 1 −/− mice. We found no significant differences in MARCO + SIGNR1 + MZM ( Figure S2A ) and B220 + CD93 − IgM hi CD23− ( Figure S2B ) and IgM hi IgD− ( Figure S2C ) MZB populations. These results indicate that elevated Spt-GC and Spt-AFC responses in B6.Sle1b mice were not due to altered regulation of the MZ compartment.
IFNαR Signaling Does Not Overtly Affect Induced-GC and Ab Responses or B Cell Affinity Maturation to T-Dependent Antigen Immunization
We next asked whether IFNαR signaling contributes to overall induced-GC responses and the quality of Ab responses generated against T-dependent antigens. We observed no significant differences in the percentage of total GC B cells at 14 days post-immunization with 4-hydroxy-3-nitrophenylacetyl-conjugated chicken γ-globulin ( Immunohistology and the quantitative analysis of the GC size of these two strains were comparable ( Figure S3E ).
Whereas we found reduced serum titers of high-affinity NP4-specific IgG ( Figure S3F strains. Collectively, these data suggest that T1IFN signaling does not play a major role in the GC and Ab responses or B cell affinity maturation to T-dependent foreign antigen in both autoimmune and non-autoimmune mice.
IFNαR Signaling in B Cells Is Required for AutoAb-Producing AFC Development and AutoAb Production in B6.Sle1b Mice
To determine the B-cell-intrinsic requirement of IFNαR signaling in Spt-GC, Spt-AFC, and autoAb responses in B6.Sle1b mice, we generated mixed bone marrow (BM) chimeras by reconstituting lethally irradiated mu mutant (uMT) mice, which lack mature B cells, with a mixture of BM (80% uMT and 20% derived from either B6.Sle1b or Sle1b.IFNαR 1 BM).
The expression of IFNαR 1 on B cells following reconstitution was confirmed by flow cytometry ( Figure 3A ). We found significantly reduced numbers of ANA-reactive AFCs in the spleen ( Figures 3D and 3E ), reduced titers of total IgG2c subtype antibodies ( Figure 3H ), and reduced serum titers of IgG 2c ANAs (Figures 3I and 3J) Figure 3B ) or Tfh ( Figure 3C ) or in total IgM + or IgG + AFCs (data not shown). Interestingly, a significantly reduced number of dsDNA-and nucleosomespecific AFCs was seen in the BM of recipient mice that were reconstituted with Sle1b.IFNαR 1 −/− BM than in B6.Sle1b control BM ( Figures 3F and 3G ). These data indicate that IFNαR signaling in B cells is required for autoAb-producing splenic and BM AFC responses and autoAb production, suggesting the cell-intrinsic role of IFNαR signaling in autoreactive B cell development into autoAb-producing AFCs, potentially via the extrafollicular AFC and the GC-AFC pathways.
IFNαR Signaling Promotes the Accumulation of DNA-Reactive B Cells in the GC Compartment of B6.Sle1b Mice
Using a p-azophenyl arsonate (Ars) and DNA dual-reactive heavy chain knockin (named HKIR) B cell transfer system Rahman et al., 2007) , we previously showed that HKIR B cells with DNA reactivity were negatively regulated by the GC tolerance mechanism, but expression of the Sle1b sublocus in HKIR B cells (named HKIR.Sle1b) rendered these cells capable of accumulating in the GCs (Wong et al., 2012) . Figure 4C ). However, the overall percentage of B220 + GL7 hi CD95 hi total GC B cells between the two groups did not differ significantly, confirming a consistent total GC response to immunization ( Figure 4B ). Histological analysis for HKIR E4 + cells within IgD neg GL7 + GCs ( Figure 4D ), quantitative analysis for E4 + cells/GC area ( Figure 4E ), and E4 fluorescence intensity in GCs ( Figure 4F ) confirmed that the recipients of Sle1b.IFNαR 1 −/− .HKIR cells had quantitatively reduced HKIR E4 + GC responses compared to mice that received B6.Sle1b.HKIR B cells, although overall GC areas did not differ between the two groups ( Figure 4G ).
E4 serum Ab titers 14 days post-B cell transfer (21 days postprimary immunization) were lower in mice receiving Sle1b. IFNαR1 −/− .HKIR B cells than Sle1b.HKIR B cells ( Figure  4H ). We also found two-fold fewer long-lived E4 + AFCs in mice receiving Sle1b.IFNαR1 −/− .HKIR B cells than Sle1b.HKIR B cells 30 days after B cell transfer ( Figure 4I ), although the difference did not reach statistical significance due to an outlier in each group. These results show that B-cell-intrinsic IFNαR signaling is required for autoreactive B cell development in the GC pathway.
Transcriptomic Analysis of Non-GC and GC B Cells Shows Differentially Expressed Genes in Multiple Signaling Pathways in the Absence of IFNαR
To determine how IFNαR signaling in B cells may promote autoreactive B cell development into the AFC and GC pathways at the molecular signaling level, we sorted non-GC and GC B cells from B6.Sle1b and B6.Sle1b.IFNαR 1 −/− mice using fluorescence activated cell sorting (FACS) and analyzed the transcripts of these cell subsets by RNA sequencing. We first generated a heatmap for differentially expressed genes showing ≥2-fold differences in GC B cells and non-GC B cells between the strains after hierarchical clustering ( Figure 5A ). We then used ingenuity pathway analysis to identify major signaling pathways that represented the differentially expressed genes (see Table S1 ). We subsequently used interferome to identify interferon-regulated genes associated with T1IFN signaling (Rusinova et al., 2013) . Genes differentially regulated between B6.Sle1b and Sle1b.IFNαR 1 −/− non-GC and GC B cells were associated with cytokine signaling ( Figure   5B ), BCR signaling ( Figure 5C ), transcriptional regulation (including NF-κB signaling; Figure 5D ), DNA repair ( Figure 5E ), actin cytoskeleton ( Figure 5F ), and inducible T-cell costimulator (ICOS) ligand signaling ( Figure 5G ). Figure 6B ). We saw reduced phosphorylation of Syk ( Figure 6C ) and reduced expression of BLNK ( Figure 6D ) in B220 + GL7 hi CD95 hi E4 + GC B cells of the HKIR. Sle1b.IFNαR 1 −/− genotype than in B220 + GL7 hi CD95 hi E4 + GC cells of the HKIR.Sle1b genotype. These results indicate that B-cell-intrinsic IFNαR signaling helps maintain BCR signaling in non-GC and GC B cells in B6.Sle1b mice at a level that is above the threshold for tolerance induction, resulting in the development of autoreactive B cells into the AFC and GC pathways.
GC B-Cell-Intrinsic IFNαR Signaling Maintains Spt-GCs and Enhances Class-Switched ANA Production
Changes in the epigenetic landscape of B cells due to transcriptional differences in multiple signaling pathways between the B6.Sle1b and Sle1b. Figure 7I ). Altogether, these data indicate a GC B-cell-intrinsic role of T1IFN signaling in autoreactive B cell development and production of class-switched autoAbs in B6.Sle1b mice.
DISCUSSION
T1IFN promotes SLE disease in both mouse and human, making this cytokine and its signaling pathway an attractive target for SLE therapeutics (Kiefer et al., 2012; Theofilopoulos et al., 2005) . Whereas most studies in mouse and human have suggested T1IFN to be a therapeutic target for SLE patients with the disease activity, we focused our current studies on determining whether T1IFN signaling can be a target for an early intervention for SLE patients with elevated T1IFN activity prior to disease onset. For this purpose, we have used B6.Sle1b mice that develop high titers of autoAbs due to altered B cell tolerance, but they do not develop full-blown disease (Wong et al., 2012) . Thus, the B6.Sle1b mouse model allows for the investigation of T1IFN signaling in the initial loss of tolerance without the confounding effects of systemic inflammation and severe disease in other SLE mouse models. Here, we show that T1IFN signaling elicits an important role in initiating SLE in addition to its established role in promoting end-stage pathology (Bagavant and Fu, 2009 ). In SLE-prone B6.Sle1b mice, we found that IFNαR expression is required for elevated Spt-GC and Spt-AFC responses and increased titers of serum autoAbs. Furthermore, B-cell-intrinsic IFNαR signaling within the GC is required for altered B cell selection that promotes the development of autoreactive B cells and class-switched autoAbproducing AFCs and autoAbs.
IFNαR signaling in BXD2 mice and B6.Sle1.Sle2.Sle3 mice results in aberrant localization of autoantigen-carrying MZBs to the B cell follicle (Li et al., 2015; Wang et al., 2010; Zhou et al., 2011) . This mislocalization of MZBs correlates with a dissipation of the MZMs that regulate the entry of apoptotic cell-derived autoantigens into the B cell follicle (Li et al., 2015) . Therefore, the direct role of B-cell-intrinsic T1IFN signaling in autoreactive B cell development in the AFC and GC pathways may not be determined by studies using the BXD2 model. In the B6. Collectively, studies of different SLE mouse models that exhibit BCR hyperactivation, TLR7 overexpression and/or hyperactivation, and/or enhanced IFNαR signaling indicate the likelihood that there is a level of synergy between these signaling events. Together, they function to achieve a certain B cell activation threshold that is required for loss of tolerance and autoreactive B cell differentiation through the AFC and GC pathways. When other signals, such as BCR and TLR signaling, are robust, IFNαR signaling is not required to meet the activation threshold. However, when the signaling is lesser by these receptors, IFNαR signaling synergy is required to push B cells over the activation threshold. These differences in signal integration are likely to be present in human patients as well and further support personalized medicine approaches to the implementation of IFN-focused therapeutics.
Both B6 and B6.Sle1b GC B cells exhibited a significant increase in IFNαR expression, and GC B-cell-specific deletion of IFNαR in B6.Sle1b mice resulted in reduced GC and IgG2c ANA responses. Together, these results suggest that IFNαR signaling controls the selection of B cells within the GC in a B-cell-intrinsic manner. Several potential sources of T1IFN have been proposed for promoting SLE development. Diphtheria-toxin-mediated depletion of plasmacytoid dendritic cells (pDCs), which are believed to be the major source for T1IFN, in BXSB mice suggested that pDCs are required for SLE development (Ganguly et al., 2013; Rowland et al., 2014) . Further studies have proposed pDCs as the predominant source of T1IFN in SLE patients (Gujer et al., 2011; Huang et al., 2015) . Although systemic overexpression of IFNα has been shown to promote changes in somatic hypermutation (Moisini et al., 2012) , a functional block of pDC-derived IFNα with Siglec-H-targeted antibodies did not have a significant effect on B cell selection, suggesting the contribution of IFNα from another source to regulate B cell tolerance at the GC checkpoint. Follicular dendritic cells (FDCs) have recently been shown to produce IFNα within the GC microenvironment (Das et al., 2017) . Collectively, these results suggest that, although pDCderived IFNs promote SLE disease, local FDC-produced IFNα may directly contribute to loss of B cell tolerance in GCs.
Recent studies have shown that transitional type 1 (T1) B cells expressed elevated levels of ifnb, ifna1, ifna4, and ifna7 mRNA in autoimmune BXD2 mice to promote survival of these transitional B cells (Hamilton et al., 2017) . Consistent with this recent report, we found a modest reduction in the percentage of T1 B cells in Sle1b.IFNαR 1 −/− mice compared to B6.Sle1b mice. Therefore, we do not rule out the role of IFNb in T1 B cell survival and potential differentiation of these cells into AFCs outside of GCs. Whereas the previous paper (Hamilton et al., 2017) showed dependence of T1 B cell survival on IFNb in a mixed bone marrow chimeric environment where IFNb + and IFNb neg T1 B cells competed for the space and survival signal, T1 B cell survival in B6.Sle1b mice in a non-competitive environment only modestly depended on IFNb signaling through IFNαR. These two systems are fundamentally different; in their system, B cells lack the ability to produce IFNb, whereas in our system they lack the ability to sense it.
In summary, our current studies have revealed a greater understanding of how B-cellintrinsic T1IFN signaling contributes to the initial loss of B cell tolerance and the development of autoreactive B cells into the AFC and GC pathways, driving autoimmunity in SLE models that do not exhibit hyperactive BCR and TLR signaling. Our studies on T1IFN signaling have implications in predicting SLE patients who might respond to anti-IFNαR therapy based on T1IFN activity. Our studies also identify applications of the anti-IFNαR therapy for an early intervention in SLE-susceptible individuals with an elevated T1IFN activity prior to disease onset, which may prevent autoreactive B cell development into the AFC and GC pathways and block disease progression.
EXPERIMENTAL PROCEDURES
Additional materials and methods can be found in the Supplemental Experimental Procedures. B6.SJL Ptprc < b > /BoyJ (B6.SJL-CD45.1 + ) mice were purchased from the Jackson Laboratory and bred in house. B6.Sle1b and B6.HKIR mice were described previously (Morel et al., 2000; Notidis et al., 2002) . Female mice of various ages (8-10 weeks, 3 months, and 6 months old) were used for all experiments. All animals were housed at Penn State Hershey Medical Center in specific pathogen-free animal facility. All procedures were performed in accordance with the guidelines approved by our Institutional Animal Care and Use Committee.
ELISpot Assays
ELISpot assays were performed as described (Wong et al., 2012) . Briefly, splenocytes in RPMI containing 10% fetal bovine serum were plated at a concentration of 1 × 10 5 cells/ well onto anti-IgM-, anti-IgG-, salmon sperm dsDNA-(Invitrogen, Grand Island, NY), calf thymus histone-(Sigma Aldrich, St. Louis, MO), or nucleosome-coated plates (Millipore, Bedford, MA). Serially diluted (1:2) cells were incubated for 6 hr at 37°C. IgM-producing AFCs were detected using biotinylated anti-mouse IgM (Jackson ImmunoResearch, West Grove, PA) and streptavidin (SA)-alkaline phosphatase (Vector Laboratories, Burlingame, CA). IgG-producing AFCs were detected using alkaline phosphatase-conjugated anti-mouse IgG (Molecular Probes, Grand Island, NY). dsDNA-, histone-, and nucleosome-specific AFCs were detected by biotinylated anti-kappa Ab (Invitrogen, Grand Island, NY) and SAalkaline phosphatase or alkaline phosphatase-conjugated anti-mouse IgG (Molecular Probes, Grand Island, NY). Plates were developed using the Vector Blue Alkaline phosphatase Substrate Kit III (Vector Laboratories, Burlingame, CA). ELISpots were enumerated using a computerized ELISpot plate imaging and analysis system (Cellular Technology, Shaker Heights, OH).
Serology: Ig and ANA Titers
Ig and ANA titers were measured by ELISA as previously described (Wong et al., 2012) . Briefly, for IgG or IgM detection, ELISA plates (Thermo Fisher Scientific, Waltham, MA) were coated with anti-IgM or anti-IgG (Invitrogen, Grand Island, NY) capture antibodies and detected using biotinylated antimouse IgM (Jackson ImmunoResearch, West Grove, PA) or alkaline-phosphatase conjugated anti-mouse IgG (Molecular Probes, Grand Island, NY). Total IgG autoAb titers were measured in plates coated with salmon sperm dsDNA (Invitrogen, Grand Island, NY), histone (Sigma Aldrich, St. Louis, MO), or nucleosome and detected with biotinylated anti-kappa Ab (Invitrogen, Grand Island, NY). IgG subtypespecific autoAb titers were detected by biotinylated-IgG1, -IgG2b, and AP-IgG2c Abs (Southern Biotech, Birmingham, AL). Biotinylated antibodies were detected by SA-alkaline phosphatase (Vector Laboratories, Burlingame, CA). The plates were developed by the PNPP (p-nitrophenyl phosphate, disodium salt; Thermo Fisher Scientific, Rockford, IL) substrates for alkaline phosphatase and read at γ405 nm.
Calcium Flux Assay
Purified B cells were incubated with Fura Red, AM (Molecular Probes) and Fluo-3, AM (Molecular Probes) Calcium dyes at 37°C in dye-free RPMI (Gibco). Prior to analysis, samples were rested in the dark at room temperature for 30 min and heated to 37° immediately prior to analysis. During flow cytometric analysis, a baseline reading was acquired from each sample for 1 min prior to stimulation of the cells with 1,5, or 10 μg/mL anti-IgM (Jackson ImmunoResearch) followed by 3 min of further acquisition on the BD LSR II flow cytometer. 
Generation of Mixed BM Chimeric Mice
Phospho Flow
Phospho flow was performed as previously described (Khalil et al., 2012) . Briefly, total splenocytes were isolated and immediately fixed in 1% paraformaldehyde in RPMI 1640 and incubated for 15 min at room temperature. Fixed splenocytes were washed in PBS solution prior to red blood cell (RBC) lysis. After RBC lysis, 1 × 10 6 total splenocytes were permeabilized in BD phosphor-flow perm buffer II and stained according to the manufacturer's protocol.
Immunization
Mice were immunized with 200 μg/mouse with NP-CGG (Biosearch Technologies) in CFA (Sigma) followed by a booster immunization with 100 μg/mouse of NP-CGG in Incomplete Freunds Adjuvant 7 days later.
Statistical Analysis
Comparisons of two groups were analyzed using an unpaired, nonparametric, MannWhitney, Student's t test, whereas one-way ANOVA, with a follow-up Tukey multiplecomparison test, was used to compare morethan two groups. GraphPad Prism 6 software (La Jolla, CA) was used for all analyses. Wherever indicated, NS indicates non-significant, *p < 0.05, **p < 0.01, and ***p < 0.001. Horizontal bars reflect mean values, and error bars reflect SD of the mean unless otherwise indicated. (G-J) Analysis of serum titers of IgM (G), IgG (H), IgG1 (I) , and IgG2c (J) antibodies in 6-month-old mice by ELISA. Each symbol represents a mouse, and these data represent at least two-three independent experiments. Statistical significance was determined by one-way ANOVA with a follow-up Tukey multiple-comparison test (NS, not significant, *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001). (E-G) Analysis of serum titers of dsDNA-reactive (E), histone-reactive (F), and nucleosomereactive (G) ANAs in the sera of 6-month-old female mice of the indicated genotypes (key at bottom of figure) by ELISA. These data are representative of two independent experiments, and each symbol represents a mouse. Statistical significance was determined by one-way ANOVA with a follow-up Tukey multiple-comparison test (**p < 0.01, ***p < 0.001, ****p < 0.0001). (I and J) Analysis of dsDNA-reactive (I) and nucleosome-reactive IgG2c (J) in the sera of these mice. These data represent one experiment of four or five mice of each genotype. Statistical significance was determined using an unpaired, nonparametric Mann-Whitney Student's t test (NS, not significant, *p < 0.05, **p < 0.01, ***p < 0.001). (E-G) The number of E4 + cells per μm 2 GC area (E), the fluorescence intensity of E4 staining (F), and the total GC areas (G) were measured for 10 GCs per spleen section. Each symbol represents a germinal center. (H) HKIR E4 + B-cell-produced serum Ab titers were measured 14 days post-B cell transfer. (I) HKIR E4 + AFCs in the bone marrow were quantified 30 days post-B cell transfer. Each symbol represents a mouse. These data are obtained from three independent experiments. Statistical significance was determined using an unpaired, nonparametric Mann-Whitney Student's t test (NS, not significant, *p < 0.05, **p<0.01, ***p<0.001). Gene groups from four patterns of gene expression were collected, and interferon-associated gene expression was confirmed by interferome and follow-up pathway analysis using ingenuity pathway analysis as listed in Table S1 . These data are obtained from two independent experiments, each involving three mice per genotype. Statistical significance was determined using an unpaired, nonparametric MannWhitney Student's t test (*p < 0.05). 
